evidence/gaps
Cochrane · systematic review · CD009128

Sweet potato for type 2 diabetes mellitus

Ooi, CP, Loke, SC · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

Metabolic and Endocrine Disorders2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
2
No studies
5
Included studies
NR
No studies 5 · 71.4%Ungraded 0 · 0%Very low 2 · 28.6%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Ipomoea batatas (Caiapo) tablets compared to placebo for type 2 diabetes mellitus

Population: people with type 2 diabetes mellitus
7 questions
OutcomeEffectEvidenceStatus / GRADE
Morbidity
Ipomoea batatas (Caiapo) tablets vs placebo
no estimate extractedNRNo studies
Adverse effects
Ipomoea batatas (Caiapo) tablets vs placebo
no estimate extracted3 studies · 140 participantsVery low
Downgraded: risk of bias, imprecision
Health‐related quality of life
Ipomoea batatas (Caiapo) tablets vs placebo
no estimate extractedNRNo studies
Well‐being
Ipomoea batatas (Caiapo) tablets vs placebo
no estimate extractedNRNo studies
Functional outcomes
Ipomoea batatas (Caiapo) tablets vs placebo
no estimate extractedNRNo studies
Costs
Ipomoea batatas (Caiapo) tablets vs placebo
no estimate extractedNRNo studies
HbA1c [%] (final values)
Ipomoea batatas (Caiapo) tablets vs placebo
no estimate extracted2 studies · 122 participantsVery low
Downgraded: risk of bias, imprecision, indirectness